Women and the elderly may see better results with cholesterol-lowering drugs, according to United Kingdom researchers. Their study included data on 5000 patients who were released from the hospital following a heart attack over an 8-year period. The researchers examined the level of cardiovascular outcomes or deaths in this group and whether they had received statin treatment.
The evidence, from a combined Tayside (Scotland) and Bristol (England) research project, found that individuals treated with statins had reduced rates of cardiovascular outcomes and death, compared with patients who were not treated. The level of benefit was observed across all patient groups. Furthermore, the study included a higher percentage of women and showed that they had positive results. (The findings were reported recently in the British Medical Journal.)
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs